Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028:…
GlobalData’s patient-based forecast reveals that the BRAF inhibitor market for melanoma will reach a key milestone by 2028, with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer therapy
US FDA approves cancer therapy by Johnson & Johnson and Legend Biotech
The treatment, Carvykti/Cilta-cel, belongs to a class of drugs known as CAR-T therapies, or chimeric antigen receptor T-cell…
Gilead may soon buy Immunomedics in deal over $20 billion
The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports
Stevioside can increase efficiency of cancer therapy using magnetic nano particles: Scientists
Coating nanoparticles with stevioside improved the cellular uptake of the nano-magnets in glioma C6 cancer cells and enhanced its…
Indian study may develop therapeutics for tongue cancer
Identify a specific microRNA (miRNAs) called ‘miR-155’ that is over-expressed in tongue cancer
USFDA extends review of Bristol Myers’ cancer therapy acquired in Celgene deal
The company said it had submitted additional information on the therapy known as liso-cel, which was considered a major amendment…